Evolution of CD4+ T-cell count among AIDS patients in socially unequal contexts;Evolução da contagem de células T CD4+ de portadores de AIDS em contextos socialmente desiguais

Cadernos de Saude Publica

Volumn 23, Issue 8, 2007, Pages 1955-1963

  Patroclo, Maria Aparecida De Assis ^a   Medronho, Roberto De Andrade ^b  

^a Secretaria de Estado da Saude de Sao Paulo   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Cell count; Poverty areas; T lymphocytes

Indexed keywords

EID: 34548828521     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2007000800022     Document Type: Article

References (21)

1. Garret L. A próxima peste: as novas doenças de um mundo em desequilíbrio. Rio de Janeiro: Editora Nova Fronteira; 1994.
2. Biolo A, Seligman BGS, Sprinz E, Rowlands-Jones SL. In: Spriz E, Finkelsztejn A, et al. Rotinas em HIV e AIDS. Porto Alegre: Editora Artes Médicas Sul; 1999. p. 26-9.
3. Pokhrath H. HIV-1 transmission and acute HIV-1 infection. Br Med Bull 2001; 58:109-27.
4. Piketty C, Weiss L, Thomas F, Mohamed AS, Belec L, Kazatchkine MD. Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. J Infect Dis 2001; 183:1328-35.
5. Yerly S, Kaiser L, Perneger TV, Cone RW, Opravil M, Chave JP, et al. Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. AIDS 2000, 14:243-49.
6. Mellors JW, Munoz A, Giorgi J, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1996; 126:946-54.
7. Chaisson RE, Keruly JC, Moore RD. Race, sex drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995; 333:751-6.
8. Hogg RS, Strathdee SAA, Craib KJ, Oshanghnessy MV, Montner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet 1994; 344:1120-4.
9. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, et al. Positive effects of combined antiretroviral therapy on CD4+ cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
10. Bucy RP, Hockett RD, Derdeyn CA, Saag K, Squires M, Sillers RT, et al. Initial increase in blood CD4 (+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 1999; 103:1391-8.
11. Le Moing V, Thiebaut R, Chene G, Leport C, Cailleton V, Michelet C, at al. Predictors of long - term increase CD4 (+) cell counts in human immunodeficiency virus infected patients receiving a protease inhibitor containing antiretroviral regimen. J Infect Dis 2002; 185:471-80.
12. Highly active antiretroviral therapy including protease inhibitors does not confer a unique CD4 cell benefit. The AVANTI and INCAS Study Groups. AIDS 2000; 14:1383-8
13. Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003; 17:1675-82.
14. Pezzotti P, Phillips AN, Dorrucci M, Lepri AC, Galai N, Vlahov D, et al. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with know dates of seroconversion. BMJ 1996; 313:583-6.
15. Swati B, Gilbert RL, Brady AR, Linvingstone SJ, Evans BG. CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990-1998. AIDS 2000; 14:853-61.
16. Hofer CB, Schechter M, Harrison LH. Effectiveness of antiretroviral therapy among patients who attend public HIV clinics in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2004; 36:967-71.
17. Szwarcwald CL, Bastos FI, Barcellos C, Pina MF, Esteves MAP. Health conditions and residential concentration of poverty: a study in Rio de Janeiro, Brazil. J Epidemiol Community Health 2000; 54:530-6.
18. Katz MH, Hsu L, Lingo M, Woelffer G, Schwarcz SK. Impact of socioeconomic status on survival with AIDS. Am J Epidemiol 1999; 148:282-91.
19. Kopp C, Lang S, von Overbeck J. Socio-demographic and life-style factors in a Swiss study of HIV non-progression. Schweiz Med Wochenschr 1999; 129:1397-404.
20. McFarland W, Chen S, Hsu L, Schwarcz S, Katz M. Low socioeconomic is associated with a higher rate of died the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 33:96-103.
21. Patroclo MAA. Perfil de portadores de HIV/AIDS em áreas socialmente desiguais [Dissertação de Mestrado]. Rio de Janeiro: Núcleo de Estudos de Saúde Coletiva; Universidade Federal do Rio de Janeiro; 2005.